Quest Diagnostics to Speak at the 44th Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
Quest Diagnostics (NYSE: DGX) will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 12, 2026 at 4:30 p.m. PT. Jim Davis, Chairman, CEO and President, and Sam Samad, EVP and CFO, will discuss the company’s strategy, performance, and market trends during a presentation and Q&A.
The session will be webcast live and available at ir.QuestDiagnostics.com; an archived webcast will be posted within 24 hours and will remain available through February 11, 2026.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
Peers in Diagnostics & Research were mostly negative, with Labcorp (LH) down 1.86% and several others slightly lower, broadly aligning with DGX’s -1.65% move ahead of this neutral conference update.
Market Pulse Summary
This announcement focused on Quest Diagnostics’ participation in the 44th J.P. Morgan Healthcare Conference, where senior leadership planned to discuss strategy and market trends on January 12, 2026. A live and archived webcast, available through February 11, 2026, offered investors additional insight beyond standard filings. Observers would typically track any new strategic details or long-term priorities discussed during the presentation.
AI-generated analysis. Not financial advice.
The presentation and Q&A session will be webcast live during the conference and will be available at ir.QuestDiagnostics.com. In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until February 11, 2026.
About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-44th-annual-jp-morgan-healthcare-conference-302647252.html
SOURCE Quest Diagnostics